1-[4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-2-pyridinyl]-2-(2-fluoroprop-2-enoxy)ethanone
C17H14Cl2F2N2O3 — CID 158247389
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-2-pyridinyl]-2-(2-fluoroprop-2-enoxy)ethanone
1-[4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-2-pyridinyl]-2-(2-fluoroprop-2-enoxy)ethanone (PubChem CID 158247389) has the molecular formula C17H14Cl2F2N2O3 and a molecular weight of 403.21 g/mol. Its IUPAC name is 1-[4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-2-pyridinyl]-2-(2-fluoroprop-2-enoxy)ethanone.
Molecular Properties
| Compound Name | 1-[4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-2-pyridinyl]-2-(2-fluoroprop-2-enoxy)ethanone |
|---|---|
| PubChem CID | 158247389 |
| Molecular Formula | C17H14Cl2F2N2O3 |
| Molecular Weight | 403.21 g/mol |
| Exact Mass | 402.03 |
| IUPAC Name | 1-[4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-2-pyridinyl]-2-(2-fluoroprop-2-enoxy)ethanone |
| SMILES | C=C(F)COCC(=O)c1nc(-c2ccc(Cl)c(OC)c2F)cc(N)c1Cl |
| InChI | InChI=1S/C17H14Cl2F2N2O3/c1-8(20)6-26-7-13(24)16-14(19)11(22)5-12(23-16)9-3-4-10(18)17(25-2)15(9)21/h3-5H,1,6-7H2,2H3,(H2,22,23) |
| InChIKey | JOJQQWXQGYTVAN-UHFFFAOYSA-N |
| XLogP | 4.47 |
| TPSA | 74.44 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 403.21 |
| LogP ≤ 5 | 4.47 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158247389 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.